Assignee
NEXTGEN BIOSCIENCE CO LTD
KR·4 granted patents·0 citations·filing 2022–2023
Top patents by PatentIndex Score
4 records- 0162US12404252B2Salt of 2-amino-2-(2-(1-decyl-1H-1,2,3-triazol-4-yl)ethyl)propane-1,3-diol, and pharmaceutical composition containing sameNEXTGEN BIOSCIENCE CO LTD·Filed 2022·Granted Sep 2, 2025·0 cites·8 claims
- 0260US11957665B1Pharmaceutical composition for preventing or treating alopecia areata acting as a functional antagonist for S1PR1 and S1PR4NEXTGEN BIOSCIENCE CO LTD·Filed 2023·Granted Apr 16, 2024·0 cites·10 claims
- 0359US12048689B2Pharmaceutical composition for preventing or treating inflammatory bowel disease acting as a functional antagonist for S1PR1 and S1PR4NEXTGEN BIOSCIENCE CO LTD·Filed 2023·Granted Jul 30, 2024·0 cites·6 claims
- 0454US12145929B2Piperidine derivative and pharmaceutical composition for inhibiting autotaxin comprising sameNEXTGEN BIOSCIENCE CO LTD·Filed 2022·Granted Nov 19, 2024·0 cites·15 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →